Clinical Trial: RAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCT

U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07781891) titled 'RAPID: Phase 2 Platform Trial Of Promising Drugs For AYA Patients With R/R Ewing Sarcoma & DSRCT' on Aug. 20.

Brief Summary: The goal of this clinical research study is to learn if new anticancer drugs or drug combinations can help to control relapsed/refractory ES, DSRCT, or SRCS.

Study Start Date: Feb. 01, 2027

Study Type: INTERVENTIONAL

Condition: Ewing Sarcoma

Intervention: DRUG: LX-101

Given by injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: M.D. Anderson Cancer Center

Disclaimer: Curated by HT Syndication....